New drug shows promise against tough lung cancer in early trial
Disease control
Completed
This study tested a new drug called ensartinib in 131 people with advanced solid tumors, including a type of lung cancer driven by an ALK gene change. The main goals were to find the safest dose and see if it shrinks tumors. Results helped guide further research on this targeted …
Phase: PHASE1, PHASE2 • Sponsor: Xcovery Holdings, Inc. • Aim: Disease control
Last updated Jun 12, 2026 12:03 UTC